PaxMedica News - PXMD

Company Name	Stock Ticker Symbol	Market	Type
PaxMedica Inc	PXMD	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.06	-6.67%	0.84	17:18:23

Open Price	Low Price	High Price	Close Price	Prev Close
0.9666	0.725	0.97	0.8433	0.90

more quote information »

Recent News

Date	Time	Source	Heading
11/30/2023	16:07	EDGAR2	Form 8-K - Current report
11/29/2023	16:33	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
11/29/2023	16:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/29/2023	16:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/29/2023	16:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/29/2023	16:05	EDGAR2	Form 8-K - Current report
11/22/2023	16:24	EDGAR2	Form 8-K - Current report
11/22/2023	16:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/21/2023	08:51	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
11/21/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
11/17/2023	08:00	GLOBE	PaxMedica Inc. Featured in Syndicated Broadcast Highlighting..
11/16/2023	16:27	EDGAR2	Form S-1/A - General form for registration of securities..
11/09/2023	08:00	GLOBE	PaxMedica's Chief Medical Officer Discusses FDA Meeting..
11/09/2023	07:18	EDGAR2	Form 8-K - Current report
11/09/2023	06:02	EDGAR2	Form S-1 - General form for registration of securities under..
11/02/2023	08:30	GLOBE	PaxMedica Engages Bourne Partners to Explore Future..
10/31/2023	08:00	GLOBE	PaxMedica Acquires Suramin Research Assets from Rediscovery..
10/30/2023	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/30/2023	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/30/2023	16:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/30/2023	16:05	EDGAR2	Form 8-K - Current report
10/30/2023	11:30	GLOBE	PaxMedica Announces 1-for-17 Reverse Stock Split
10/26/2023	13:51	GLOBE	PaxMedica's Research on Low Dose Suramin for Autism Spectrum..
10/18/2023	10:10	GLOBE	The Bell2Bell Podcast featuring Howard Weisman, CEO and Buzz..
9/27/2023	16:05	EDGAR2	Form 8-K - Current report
9/11/2023	16:05	EDGAR2	Form DEF 14A - Other definitive proxy statements
9/06/2023	16:25	EDGAR2	Form 8-K - Current report
9/01/2023	16:33	EDGAR2	Form PRE 14A - Other preliminary proxy statements
8/30/2023	16:26	EDGAR2	Form 144 - Report of proposed sale of securities
8/30/2023	16:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/30/2023	16:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/30/2023	16:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/30/2023	08:00	GLOBE	PaxMedica to Present at the H.C. Wainwright 25th Annual..
8/17/2023	16:05	EDGAR2	Form 8-K - Current report
8/16/2023	09:00	EDGAR2	Form 8-K - Current report
8/16/2023	08:30	GLOBE	PaxMedica Appoints David Hough M.D. as Chief Medical Officer
8/09/2023	17:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/2023	16:30	EDGAR2	Form 8-K - Current report
8/09/2023	16:15	GLOBE	PaxMedica, Inc. Announces Second Quarter 2023 Financial..
8/04/2023	16:05	EDGAR2	Form 8-K - Current report
7/28/2023	16:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/28/2023	16:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/28/2023	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/24/2023	08:15	EDGAR2	Form 8-K - Current report
7/24/2023	08:00	GLOBE	PaxMedica Announces Positive Top Line Results from the..
7/06/2023	08:00	GLOBE	PaxMedica Grants Exclusive Pharmacy Distribution Rights for..
6/22/2023	08:30	GLOBE	PaxMedica Comments on Common Stock Volatility
6/20/2023	08:30	GLOBE	PaxMedica CEO Interviewed by The BRAIN Foundation
6/14/2023	08:00	GLOBE	PaxMedica Submits Clinical Trial Request in Autism Spectrum..
6/08/2023	08:00	GLOBE	PaxMedica Enters Research Collaboration Agreement With..